Ampio Pharmaceuticals, Inc. (AMPE)

USD 0.03

(20.42%)

Gross Profit Summary of Ampio Pharmaceuticals, Inc.

  • Ampio Pharmaceuticals, Inc.'s latest annual gross profit in 2023 was -250 Thousand USD , up 87.97% from previous year.
  • Ampio Pharmaceuticals, Inc.'s latest quarterly gross profit in 2023 FY was -250 Thousand USD , up 87.97% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported a annual gross profit of -2.07 Million USD in annual gross profit 2022, down -90.04% from previous year.
  • Ampio Pharmaceuticals, Inc. reported a annual gross profit of -1.09 Million USD in annual gross profit 2021, up 7.13% from previous year.
  • Ampio Pharmaceuticals, Inc. reported a quarterly gross profit of - USD for 2023 Q2, up 100.0% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported a quarterly gross profit of -245 Thousand USD for 2023 Q1, up 33.6% from previous quarter.

Annual Gross Profit Chart of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Gross Profit of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Year Gross Profit Gross Profit Growth
2023 -250 Thousand USD 87.97%
2022 -2.07 Million USD -90.04%
2021 -1.09 Million USD 7.13%
2020 -1.17 Million USD 7.39%
2019 -1.27 Million USD -143.21%
2018 -523 Thousand USD 7.92%
2017 -568 Thousand USD 40.21%
2016 -950 Thousand USD -219.78%
2015 793.15 Thousand USD 136.65%
2014 -2.16 Million USD -28.21%
2013 -1.68 Million USD -20.66%
2012 -1.39 Million USD -7561.33%
2011 18.75 Thousand USD 0.0%
2010 - USD 0.0%
2009 - USD 100.0%
2008 -950.00 USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Gross Profit Comparison of Ampio Pharmaceuticals, Inc.

Name Gross Profit Gross Profit Difference
America Great Health 168.58 Thousand USD 248.291%
Aridis Pharmaceuticals, Inc. - USD Infinity%
Biora Therapeutics, Inc. -551 Thousand USD 54.628%
Bio-Path Holdings, Inc. -178 Thousand USD -40.449%
Better Therapeutics, Inc. -2.72 Million USD 90.839%
Calithera Biosciences, Inc. -1.38 Million USD 81.949%
Comera Life Sciences Holdings, Inc. 422.71 Thousand USD 159.142%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -22.91 Million USD 98.909%
Eloxx Pharmaceuticals, Inc. - USD Infinity%
Evelo Biosciences, Inc. - USD Infinity%
Evolutionary Genomics, Inc. -1.02 Million USD 75.526%
Finch Therapeutics Group, Inc. -7.09 Million USD 96.475%
Galera Therapeutics, Inc. -259 Thousand USD 3.475%
Innovation1 Biotech Inc. -52.69 Thousand USD -374.401%
Kiromic BioPharma, Inc. -2.79 Million USD 91.058%
Molecular Templates, Inc. 50.39 Million USD 100.496%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -109.565%
NexImmune, Inc. -1.02 Million USD 75.609%
Orgenesis Inc. -5.72 Million USD 95.633%
Panbela Therapeutics, Inc. -25.64 Million USD 99.025%
Point of Care Nano-Technology, Inc. -4601.00 USD -5333.601%
PaxMedica, Inc. Common Stock - USD Infinity%
Scopus BioPharma Inc. - USD Infinity%
Sorrento Therapeutics, Inc. 29.38 Million USD 100.851%
Statera Biopharma, Inc. -488.31 Thousand USD 48.803%
TRACON Pharmaceuticals, Inc. -232 Thousand USD -7.759%
Trevena, Inc. 1.45 Million USD 117.182%
Vaxxinity, Inc. -2.23 Million USD 88.809%
Vaccinex, Inc. -16 Million USD 98.438%
Vicapsys Life Sciences, Inc. - USD Infinity%
Viracta Therapeutics, Inc. -492 Thousand USD 49.187%
ZIVO Bioscience, Inc. 11.61 Thousand USD 2253.316%